Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Interferon alfa-2b in High-Risk Melanoma
NCT01259934Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Nov 1996
- Primary completion
- Jun 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-2b in melanoma, sponsored by Karolinska Institutet. Started Nov 1996; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01259934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259934.